Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
New York State Workers’ Compensation Board Announces Launch Dates for OnBoard Limited Release
The New York Workers’ Compensation Board is implementing an online system called OnBoard, which will replace the paper-based claims systems and eCa
mitchell
Article
Current Used Vehicle Market Conditions: 2021 Year-End
2021 Year-End Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, KAR Global.
Workers' Comp
Article
CPT 2022: Care Management and Other CPT Coding Updates
CPT Copyright 2021 American Medical Association. All rights reserved.
Auto Casualty
Article
CPT 2022: Care Management and Other CPT Coding Updates
CPT Copyright 2021 American Medical Association. All rights reserved.
WorkCompWire
News Release
Jill Harris: For Workers’ Comp Industry, Navigating Provider Shortage Requires Fresh Thinking
Enlyte
Article
Top Auto Casualty Trends to Watch in 2022
The year 2021 brought new challenges to the auto insurance industry—from frequent shifts in miles driven to significant staffing shortages.